HIGHLIGHTS
- who: Christopher P. Klimko et al. from the Fort Detrick, MD, USA have published the Article: Efficacy of Treatment with the Antibiotic Novobiocin against Infection with Bacillus anthracis or Burkholderia pseudomallei, in the Journal: Antibiotics 2022, x of 23/Nov/2022
- what: The aim of this research was to begin to characterize the therapeutic efficacy of novobiocin in mouse models of anthrax and melioidosis. The aim of the research was to repurpose and evaluate the antimicrobial agent novobiocin (Novo), an aminocoumarin class antibiotic, as a novel therapeutic approach to counteract natural or engineered resistance to . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.